Envoy Medical, INC Form 4 insider transactions

CEO Brent Lucas acquired 32,856 shares of Envoy Medical, Inc. Class A Common Stock through the company's Employee Stock Purchase Plan.

Director Chas McKhann was granted 100,000 stock options in Envoy Medical, Inc. as part of a long-term incentive plan.

Glen A. Taylor, a Director and 10% owner of Envoy Medical, Inc., acquired 18.75 million shares of Class A Common Stock and 30 million warrants at $0.40 per share.

Envoy Medical's Interim CFO, Robert Potashnick, has acquired 15,000 stock options with a $0.53 exercise price, vesting over several years.

Envoy Medical CEO Brent T. Lucas reported significant beneficial ownership of Class A Common Stock and various derivative securities, including new stock options.

Envoy Medical's CEO, Brent T. Lucas, acquired 18,105 shares of Class A Common Stock through an employee stock purchase plan.

Envoy Medical Director Janis Smith-Gomez was granted 25,000 Class A Common Stock options with an exercise price of $0.813, expiring in 2035.

Envoy Medical Director Michael Curtis Crowe acquired 25,000 stock options at an exercise price of $0.813, set to vest from May 2026.

Envoy Medical, Inc. Director Mona Chetan Patel acquired 25,000 Class A Common Stock options with an exercise price of $0.813.

Envoy Medical Director Susan Kantor reported the acquisition of 62,500 stock options and beneficial ownership of 77,887 Class A Common Stock shares.

Envoy Medical Director Charles Brynelsen acquired 62,500 Class A Common Stock options on December 3, 2025, signaling increased insider confidence.

Glen A. Taylor, a Director and 10% owner of Envoy Medical, Inc., amended several warrants, replacing existing ones with new warrants extending their expiration dates to December 31, 2028.

Glen A. Taylor, a Director and 10% owner of Envoy Medical, Inc., has increased his beneficial ownership through direct and indirect holdings, including the acquisition of a new warrant for 750,000 shares of Class A Common Stock.

Envoy Medical, Inc. Director Mona Chetan Patel has acquired an additional 2,500 shares of Class A Common Stock, signaling increased insider confidence in the company.

Envoy Medical, Inc. Director Mona Chetan Patel reported the acquisition of 10,000 shares of Class A Common Stock, signaling increased insider confidence in the company.

Envoy Medical, Inc. CEO and Director Brent T. Lucas has reported the acquisition of additional Class A Common Stock through the company's Employee Stock Purchase Plan, increasing his direct beneficial ownership.

Envoy Medical, Inc. Director Charles Brynelsen has increased his direct ownership in the company by acquiring 50,000 shares of Class A Common Stock through open market purchases in late May 2025.

Glen A. Taylor, a director and 10% owner of Envoy Medical, Inc., filed a Form 4 detailing changes in beneficial ownership, including the acquisition of warrants.

Susan Kantor, a director at Envoy Medical, received 34,705 shares of Class A Common Stock through a pro-rata distribution.

Anzu SPAC GP I LLC converted preferred stock to common stock in Envoy Medical and distributed shares to its members.

Glen A. Taylor, a director at Envoy Medical, has reported the acquisition of warrants to purchase 500,000 shares of Class A Common Stock, along with holdings of other shares and warrants.

Envoy Medical's CEO, Brent Lucas, has reported transactions involving the acquisition of warrants and holdings of common stock and stock options.

Director Mona Chetan Patel of Envoy Medical, Inc. acquired 2,500 shares of Class A Common Stock and was granted options for 25,000 shares.

Susan Kantor, a director at Envoy Medical, acquired 18,182 shares of Class A Common Stock through a pro-rata in-kind distribution.

Anzu SPAC GP I LLC distributed 1,000,000 shares of Envoy Medical, Inc. Class A Common Stock to its members, with Dr. Whitney Haring-Smith also reporting beneficial ownership due to shared voting and investment control.

Director Mona Chetan Patel reports purchasing shares of Envoy Medical, Inc. (COCH) in multiple transactions.

Glen A. Taylor, a director and 10% owner of Envoy Medical, Inc., reported the acquisition of 500,000 Class A Common Stock warrants on August 27, 2024, related to a promissory note draw.

Director Michael Curtis Crowe acquired stock options for 25,000 shares of Envoy Medical, Inc. on August 8, 2024.

Glen Taylor, a director and 10% owner of Envoy Medical, Inc., filed a Form 4 detailing changes in his beneficial ownership, including the acquisition of warrants and holdings through related entities.

Envoy Medical's CEO, Brent Lucas, reported a pro rata distribution of Class A Common Stock and stock option holdings.